Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-007282
Filing Date
2025-09-17
Accepted
2025-09-17 16:28:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3361
  Complete submission text file 0001950047-25-007282.txt   4817
Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Ceesay Abraham (Reporting) CIK: 0001722140 (see all company filings)

Type: 144

Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42121 | Film No.: 251320385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)